Iguana Healthcare Management’s SCYNEXIS SCYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$536K Buy
5,000
+1,875
+60% +$259K 0.35% 58
2017
Q4
$580K Hold
3,125
0.38% 58
2017
Q3
$603K Buy
3,125
+312
+11% +$47.5K 0.33% 62
2017
Q2
$403K Sell
2,813
-937
-25% -$155K 0.23% 60
2017
Q1
$828K Buy
3,750
+625
+20% +$157K 0.41% 60
2016
Q4
$798K Hold
3,125
0.48% 48
2016
Q3
$968K Buy
3,125
+1,562
+100% +$330K 0.17% 77
2016
Q2
$271K Hold
1,563
0.11% 81
2016
Q1
$504K Hold
1,563
0.18% 71
2015
Q4
$776K Hold
1,563
0.26% 59
2015
Q3
$910K Hold
1,563
0.36% 63
2015
Q2
$1.1M Buy
+1,563
New +$1.12M 0.35% 55

Other funds holding SCYX

Iguana Healthcare Management's SCYX Position: Q1 2018 in Review

Iguana Healthcare Management increased its SCYNEXIS (SCYX) stake by 60% in Q1 2018, buying an estimated $259K and bringing the position to 5,000 shares worth $536K. The position accounts for 0.35% of the portfolio, ranked #58.

Iguana Healthcare Management first reported a position in SCYX in Q2 2015 and has held it in 12 quarters since. The position peaked at $1.1M in Q2 2015. 42 funds tracked by Wall St. Rank hold SCYX as of Q1 2018.

  • Iguana Healthcare Management held 5,000 shares of SCYNEXIS worth $536K as of Q1 2018.
  • Iguana Healthcare Management bought 1,875 SCYNEXIS shares in Q1 2018, an estimated $259K.
  • SCYNEXIS made up 0.35% of Iguana Healthcare Management's portfolio in Q1 2018, its #58 holding.
  • Iguana Healthcare Management first reported a position in SCYNEXIS in Q2 2015 and has held it in 12 quarters since.
  • Iguana Healthcare Management's SCYNEXIS position peaked at $1.1M in Q2 2015.
  • 42 funds tracked by Wall St. Rank held SCYNEXIS as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.